PCSK9 and experimental autoimmune encephalomyelitis: In experimental autoimmune encephalomyelitis, altering PCSK9 does not change clinical course or canonical immune readouts, and reviews of multiple sclerosis do not place PCSK9 among core disease mechanisms despite the central importance of lipid metabolism in myelin biology [135].